Bone mineral density in spanish children at the diagnosis of inflammatory bowel disease

Etna Masip1, Ester Donat2, Begoña Polo Miquel2

  • 1Pediatric Gastroenterology and Hepatology Unit, University Hospital La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. masip_etn@gva.es.

Insights

Pediatric patients with inflammatory bowel disease (IBD) often have low bone mineral density (BMD) at diagnosis. Lower weight and height are significant risk factors for reduced BMD in these children.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Endocrinology

Background:

  • The association between inflammatory bowel disease (IBD) and low bone mineral density (BMD) is established.
  • Previous research indicates potential bone density issues even at disease onset.

Purpose of the Study:

  • To assess bone mineral density (BMD) in Spanish pediatric patients diagnosed with IBD.
  • To identify potential risk factors for low BMD in this cohort at the time of diagnosis.

Main Methods:

  • A retrospective review of medical records for pediatric IBD patients diagnosed within the last 10 years.
  • Bone mineral density (BMD) was measured at diagnosis and expressed as Z-scores.

Main Results:

  • 57 pediatric IBD patients were analyzed; 5% presented with low BMD (Z-score ≤ -2 SD).
  • No significant differences in BMD were observed between Crohn's disease and Ulcerative Colitis.
  • A significant association was found between lower BMD Z-scores and lower weight and height Z-scores (p<0.05).

Conclusions:

  • Suboptimal bone density is prevalent at diagnosis in Spanish pediatric IBD patients.
  • Low weight and height at diagnosis are identified as risk factors for diminished bone density.
  • These findings underscore the importance of monitoring bone health in pediatric IBD from the point of diagnosis.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
472
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
498
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
465
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
254